OakChart

Health Catalyst Inc

HCATHealthcare·Health Information Services·USA·Micro·NASD·Nov 11 • 2:05 PM ET

1.44-0.00 (-0.24%)
2026-11-11 20:05 CET
Market cap
109.66 USD m
Revenue, TTM
272.20 USD m
Net income, TTM
-202.09 USD m
Free cash flow, TTM
6.99 USD m
EPS diluted, TTM
-2.83
P/E
-
Compare

Price

HCAT against its 20, 50 and 200-day averages
2050200beatmiss
1.502.0013.9M27.9MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HCATclose 1.4420-day 1.6350-day 1.70200-day 1.681.44

57.2% under the 52-week high of 3.36 on 11 Nov 2025. 52-week low 0.96 on 10 Apr 2026. Last 15 sessions, 36.2% high to low

Profile

HCAT
52-week range, 20% of the way up
0.963.36

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Employees1200
IPOJul 25, 2019
Beta1.52
ATR, 14d0.12
Rel volume0.99
Short float3.28%
Insider own21.79%
Inst own61.36%

Snapshot

6 groups

Valuation

Index-
Market Cap109.40M
Enterprise Value46.16M
Income-202.09M
Sales272.20M
Book/sh1.91
Cash/sh1.04
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees1200
IPOJul 25, 2019

Ratios

P/E-
Forward P/E-
PEG-
P/S0.40
P/B0.75
P/C1.38
P/FCF15.65
EV/EBITDA3.21
EV/Sales0.17
Quick Ratio1.68
Current Ratio1.68
Debt/Eq0.11
LT Debt/Eq0.08
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.83
EPS next Y-0.05
EPS next Q-0.05
EPS this Y-124.06%
EPS next Y-14.03%
EPS next 5Y-23.69%
EPS past 3/5Y1.04% 2.63%
Sales past 3/5Y4.05% 10.50%
EPS Y/Y TTM-78.38%
Sales Y/Y TTM-13.88%
EPS Q/Q268.82%
Sales Q/Q-26.26%
EarningsNov 05 AMC
EPS/Sales Surpr.35.48% 1.61%

Ownership

Insider Own21.79%
Insider Trans0.36%
Inst Own61.36%
Inst Trans-8.23%
ROA-49.02%
ROE-84.64%
ROIC-128.17%
Gross Margin32.72%
Oper. Margin-11.52%
Profit Margin-74.24%
SMA20-11.84%
SMA50-15.54%
SMA200-14.68%
Trades-

Technical

Shs Outstand76.16M
Shs Float59.56M
Short Float3.28%
Short Ratio3.97
Short Interest1.95M
52W High3.36 -57.24%
52W Low0.96 50.41%
Volatility9.54% 7.09%
ATR (14)0.12
RSI (14)38.28
Beta1.52
Rel Volume0.99
Avg Volume491.31K
Volume350,064

Performance

Perf Week-9.65%
Perf Month-17.44%
Perf Quarter-17.91%
Perf Half Y7.21%
Perf YTD-39.89%
Perf Year-46.59%
Perf 3Y-78.59%
Perf 5Y-97.09%
Perf 10Y-
Recom2.60
Target Price1.77
Prev Close1.44
Price1.44
Change %-0.24%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 21, 2026DowngradeCCanaccord GenuityBuy → Hold$1.80+25.3%
Mar 18, 2026DowngradeWWells FargoOverweight → Equal Weight$1-30.4%
Aug 27, 2025DowngradePPiper SandlerOverweight → Neutral$4+178.4%
Aug 11, 2025DowngradeCCitigroupBuy → Neutral
Aug 08, 2025DowngradeCCantor FitzgeraldOverweight → Neutral$4+178.4%
Jun 17, 2025DowngradeBBTIG ResearchBuy → Neutral
Apr 09, 2025DowngradeEEvercore ISIOutperform → In-line
Jan 08, 2025UpgradeKKeyBanc Capital MarketsSector Weight → Overweight$9+526.5%
Apr 10, 2024DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight
Jan 03, 2024UpgradeEEvercore ISIIn-line → Outperform$11+665.7%

Peers

Mkt cap
TickerCompanyMkt cap
DHDefinitive Healthcare Corp180.85M
HSTMHealthstream Inc889.57M
NRCNRC Health570.33M
EVHEvolent Health Inc550.26M
WAYWaystar Holding Corp5.56B
CCLDCareCloud Inc110.84M
CTEVClaritev Corp500.41M
PHRPhreesia Inc793.27M
OMCLOmnicell Inc1.66B
ORCLOracle Corp391.57B

Insider trading

latest 14 of 34
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Kohl SimeonChief Executive OfficerSep 14 '26Buy1.7959,000105,4392,856,385Sep 16 04:52 PM
Benjamin AlbertOfficerSep 10 '26Proposed Sale1.6735,24459,023Sep 10 05:35 PM
Benjamin AlbertOfficerSep 01 '26Proposed Sale1.70321547Sep 01 05:48 PM
Jason AlgerOfficerSep 01 '26Proposed Sale1.7017,97330,619Sep 01 05:47 PM
Benjamin LandryOfficerSep 01 '26Proposed Sale1.7013,16722,431Sep 01 05:46 PM
Benjamin AlbertOfficerJun 10 '26Proposed Sale1.6934,48558,342Jun 10 05:11 PM
Benjamin AlbertOfficerJun 01 '26Proposed Sale1.37336460Jun 01 05:37 PM
Jason AlgerOfficerJun 01 '26Proposed Sale1.3718,80425,765Jun 01 05:36 PM
Linda LlewelynOfficerJun 01 '26Proposed Sale1.378,51911,673Jun 01 05:36 PM
Benjamin LandryOfficerJun 01 '26Proposed Sale1.3713,77918,880Jun 01 05:35 PM
Benjamin AlbertOfficerMay 01 '26Proposed Sale1.34310417May 01 05:25 PM
Benjamin AlbertOfficerMar 10 '26Proposed Sale1.8570,455130,208Mar 10 08:39 PM
Jason AlgerOfficerMar 02 '26Proposed Sale1.6626,97044,768Mar 02 07:17 PM
Benjamin AlbertOfficerMar 02 '26Proposed Sale1.664,9668,243Mar 02 07:16 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IWCiShares Micro-Cap ETFAUM: 1.22B
VHTVanguard Health Care ETFAUM: 21.51B
MEDIHarbor Health Care ETFAUM: 44.19M
SCHBSchwab U.S. Broad Market ETFAUM: 44.09B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
EESWisdomTree U.S. SmallCap FundAUM: 684.87M

News

latest 14 of 200
  • Health Catalyst Misses On Adjusted EPS As The Post-Vitalware Business Shows Its True Margin Profile (Earnings Whispers) -5.66%
  • Health Catalyst: Q3 Earnings Snapshot (Associated Press)
  • Health Catalyst Reports Third Quarter 2026 Results (GlobeNewswire)
  • Health Catalyst's Debt-Free Reset Meets Its First Real Test As Migration Churn Lingers (Earnings Whispers) +14.65%
  • Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026 (GlobeNewswire)
  • Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.06% -5.49%
  • Health Catalyst Strengthens Its Board with the Appointment of Tami Reller (PR Newswire)
  • Health Catalyst appoints new CEO (Healthcare Dive)
  • Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President (GlobeNewswire)
  • Health Catalyst to Participate in Upcoming Investor Conference (GlobeNewswire)
  • Health Catalyst: Q2 Earnings Snapshot (Associated Press) -25.11%
  • Health Catalyst Reports Second Quarter 2026 Results (GlobeNewswire)
  • Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company (PR Newswire)
  • Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026 (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.030-0.0470.53056.2855.394
2026Q22026-08-060.0400.030-0.54870.4969.095
2026Q12026-05-110.0200.011-1.52970.7669.247
2025Q42026-03-120.0800.094-1.28274.6873.979
2025Q32025-11-100.0600.061-0.31676.3275.019
2025Q22025-08-070.0400.033-0.58980.7280.6210
2025Q12025-05-070.010-0.003-0.34679.4179.1812
2024Q42025-02-260.0400.073-0.33179.6179.6513
2024Q32024-11-060.0700.096-0.24476.3576.2714
2024Q22024-08-070.1200.080-0.22875.9074.9614
2024Q12024-05-090.0500.031-0.35174.7274.8215
2023Q42024-02-220.0200.012-0.52775.0873.5712
2023Q32023-11-020.030-0.003-0.38973.7773.0413
2023Q22023-08-080.050-0.011-0.58373.2172.6415
2023Q12023-05-090.050-0.037-0.59873.8771.2414
2022Q42023-02-28-0.050-0.112-0.65769.1668.2613

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.930-1.091-12.855154.94153.2
2020FY-0.680-0.727-2.909188.85187.65
2021FY-0.450-0.499-3.226241.93240.34
2022FY-0.260-0.339-2.627276.24275.4
2023FY0.1500.146-2.094295.94294.47
2024FY0.2800.312-1.155306.58306.54
2025FY0.1800.200-2.550311.14310.44
2026FY--0.043--247.9
2027FY--0.049--201.5
2028FY-0.080--217.13

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0950350.6149.9652.24
2026Q4S2026-11-0650250.7949.9652.24
2026Q4S2026-11-0250051.1849.9653.42
2026Q4S2026-11-0150151.1849.9653.42
2026Q4S2026-10-2150251.1849.9653.42
2026Q4S2026-09-2550451.1849.9653.42
2026Q4S2026-08-1960551.0549.9653.42
2026Q4S2026-08-1860453.0050.3761.67
2026Q4S2026-08-1260354.0850.3761.67
2026Q4S2026-08-1060453.6548.2861.67
2026Q4S2026-08-0760355.4548.2861.67
2026Q4S2026-08-0350060.9259.9361.67
2026Q4S2026-08-0160060.6059.0261.67
2026Q4S2026-07-2760160.6059.0261.67

Estimate history

EPS, annual-1.611-3.124-12.855-2.909-3.226-2.627-2.094-1.155-2.546-2.8263
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.244-0.331-0.346-0.589-0.316-1.282-1.529-0.5480.533
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual73.081112.574154.941188.845241.926276.236295.938306.584311.136272.2
Period201720182019202020212022202320242025TTM
Sales, quarterly76.35379.60679.41380.72176.32374.67970.75670.48756.283
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual36.49536.49536.67943.37752.62255.26258.29564.04472.02776.155
Period201720182019202020212022202320242025MRQ
Shares, quarterly60.84864.04469.48270.26770.62372.02773.74974.59876.155
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue272.20311.14306.58295.94276.24241.93188.84154.94112.57
Cost of Goods Sold Incl. D&A183.15207.00206.22203.34188.97161.69116.8084.4566.93
Gross Profit89.06104.13100.3692.6087.2680.2372.0470.4945.65
Selling, General and Administrative Excl. Other120.40144.84155.12178.36210.15194.15151.41124.91103.63
Research and Development38.4846.0956.8068.5069.2261.8353.5246.2238.08
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-31.35-40.70-54.75-85.76-122.89-113.92-79.37-54.42-57.98
Interest Expense16.5024.2517.097.297.2417.3113.726.262.59
Unusual Expense222.94120.1515.0541.1417.1229.7325.272.122.11
Net Income Before Taxes-201.38-177.26-69.17-117.79-141.68-160.11-116.21-59.95-62.12
Income Taxes0.710.720.330.36-4.28-6.90-1.190.14-0.14
Consolidated Net Income-202.09-177.97-69.50-118.15-137.40-153.21-115.02-60.10-61.98
Net Income From Continuing Operations-202.09-177.97-69.50-118.15-137.40-153.21-115.02-60.10-61.98
Net Income-202.09-177.97-69.50-118.15-137.40-153.21-115.02-240.92-114.02
EPS (Recurring)-0.61-1.34-0.98-1.58-2.41-2.79-2.46-12.78-3.08
EPS (Basic, Before Extraordinaries)-2.82-2.55-1.15-2.09-2.56-3.23-2.91-12.86-3.12
EPS (Diluted)-2.83-2.55-1.15-2.09-2.63-3.23-2.91-12.86-3.12
EBITDA14.369.80-13.32-40.55-71.36-72.81-56.34-45.21-50.57
Non-Operating Income (Expense)69.407.8517.7216.395.560.852.142.840.56
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.1321.3431.7044.0556.9647.5627.7113.033.32
Price To Sales Ratio0.480.541.391.772.087.789.114.20-
Gross Margin32.7233.4732.7431.2931.5933.1638.1545.5040.55
Operating Margin-11.52-13.08-17.86-28.98-44.49-47.09-42.03-35.12-51.50
Net Margin-74.24-57.20-22.67-39.92-49.74-63.33-60.91-155.49-101.29
Shares Outstanding76.1672.0364.0458.3055.2652.6243.3836.6836.49
Market Capitalization109.66109.66430.19532.92582.002,062.431,849.961,265.581,244.42

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue56.2870.4970.7674.6876.3280.7279.4179.61
Cost of Goods Sold Incl. D&A41.8446.0547.1048.1750.0054.9353.9155.00
Gross Profit14.4524.4423.6626.5126.3225.7925.5124.60
Selling, General and Administrative Excl. Other27.4728.2130.4134.3140.8837.4539.0937.77
Research and Development9.409.549.679.8710.9111.9613.3514.91
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-13.03-3.77-6.75-7.80-14.55-11.66-13.58-13.17
Interest Expense1.594.644.745.525.635.797.327.30
Unusual Expense12.2232.7199.7378.282.9625.436.594.33
Net Income Before Taxes40.10-40.22-110.61-90.65-22.19-40.90-23.53-20.05
Income Taxes-0.390.320.410.380.040.080.210.62
Consolidated Net Income40.50-40.54-111.03-91.03-22.23-40.98-23.74-20.67
Net Income From Continuing Operations40.50-40.54-111.03-91.03-22.23-40.98-23.74-20.67
Net Income40.50-40.54-111.03-91.03-22.23-40.98-23.74-20.67
EPS (Recurring)0.65-0.24-0.57-0.51-0.29-0.33-0.28-0.28
EPS (Basic, Before Extraordinaries)0.54-0.55-1.53-1.28-0.32-0.59-0.35-0.33
EPS (Diluted)0.53-0.55-1.53-1.28-0.32-0.59-0.35-0.33
EBITDA-3.307.215.375.08-1.941.02-1.26-2.90
Non-Operating Income (Expense)66.940.900.610.950.961.983.964.75
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.222.142.980.795.566.585.968.54
Price To Sales Ratio0.480.500.300.550.630.831.001.44
Gross Margin25.6734.6733.4335.5034.4931.9532.1230.90
Operating Margin-23.14-5.35-9.54-10.45-19.07-14.45-17.11-16.54
Net Margin71.95-57.51-156.91-121.89-29.12-50.76-29.90-25.97
Shares Outstanding76.1674.6073.7572.0370.6270.2769.4864.04
Market Capitalization109.66147.0593.45169.05200.56262.40318.05430.19

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments95.73392.00317.73363.49444.98270.87228.2833.1951.46
Short Term Receivables59.4357.7861.1947.9748.8048.3027.5727.7017.05
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets12.3513.7712.2814.8414.6110.137.465.322.11
Total Current Assets167.51463.55391.20426.30508.39329.30263.3066.2170.62
Net Property, Plant & Equipment40.4841.4539.6442.5944.4537.598.0811.025.38
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets286.75345.81264.04278.17274.76206.7429.2332.0033.26
Other Assets7.918.126.945.234.504.111.751.751.00
Total Assets502.64858.93701.81752.29832.10577.74302.36110.97110.27
Short Term Debt Incl. Current Port. of LT Debt5.41234.803.363.433.422.622.813.862.13
Accounts Payable9.3611.436.644.424.695.333.621.810.83
Other Current Liabilities74.8079.6279.0374.6584.9380.0841.7936.1327.80
Total Current Liabilities89.57325.8589.0382.5193.0588.0448.2241.8130.77
Long Term Debt165.83167.47245.71244.54201.19192.6649.8523.0410.49
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities1.460.400.150.2315.7620.943.6511.056.92
Total Liabilities256.86493.72334.89327.28310.00301.64101.7275.9048.17
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00409.85321.57
Common Equity245.78365.21366.92425.01522.10276.10200.64-374.77-259.48
Total Shareholders Equity245.78365.21366.92425.01522.10276.10200.6435.0862.09
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity245.78365.21366.92425.01522.10276.10200.6435.0862.09
Total Liabilities & Stockholders Equity502.64858.93701.81752.29832.10577.74302.36110.97110.27
Book Value Per Share3.415.706.297.699.926.375.47-10.27-7.11
Tangible Book Value Per Share-0.570.301.762.664.701.604.67-11.15-8.02
Full-Time Employees1,2001,5001,3001,2001,2001,000900700-
Price to Book Ratio0.751.211.381.313.996.846.346.02-
Return on Assets-26.14-8.91-16.25-17.34-21.73-26.14-29.08-56.03-
Return on Equity-58.26-18.99-29.84-29.02-38.39-48.25-50.99-127.58-
Return on Invested Capital-43.24-13.05-19.29-20.52-21.18-24.54-23.99-106.65-64.80
Quick Ratio1.871.424.395.175.463.745.461.582.30
Current Ratio1.871.424.395.175.463.745.461.582.30

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-202.09-177.97-69.50-118.15-137.40-153.21-115.02-60.10-61.98
Depreciation45.7050.5041.4345.2151.5341.1123.039.217.41
Other Funds (Non Cash)166.84143.2443.2153.5269.0391.4970.9419.934.53
Funds from Operations10.4215.8415.22-19.41-21.36-27.74-22.32-30.92-50.05
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital16.40-15.11-0.66-13.67-13.914.62-3.83-1.279.75
Cash from Operating Activities26.820.7314.56-33.08-35.27-23.12-26.15-32.18-40.30
Capital Expenditures-20.93-21.55-16.40-14.31-17.41-18.47-10.46-4.33-2.50
Net Assets From Acquisitions0.00-41.11-80.28-11.39-27.85-46.76-101.660.000.00
Sale of Fixed Assets and Businesses144.490.040.010.030.030.020.010.060.03
Purchase or Sale of Investments26.8298.8273.7645.976.21-74.4729.54-205.3323.88
Purchase of Investments-51.58-65.13-168.31-290.84-308.96-261.36-189.53-256.01-13.99
Sale Or Maturity of Investments78.40163.95242.07336.80315.17186.89219.0750.6837.87
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities150.3936.19-22.9020.29-39.02-139.68-82.56-209.6021.40
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.60-3.492.582.73-1.27270.3740.54207.7528.32
Repurchase of Common Pref Stock0.00-5.000.00-1.81-8.390.000.000.00-8.71
Sale of Common Pref Stock0.601.512.584.547.12270.3740.54207.7537.03
Proceedsfrom Stock Options0.601.512.413.593.15250.024.27205.0933.99
Issuance or Reduction of Debt, Net-164.37-232.29149.170.000.000.00143.7025.359.95
Change in Long Term Debt-164.37-232.29149.170.000.000.00143.7025.359.95
Issuance of Long Term Debt0.000.00152.280.000.000.00222.4847.179.95
Reduction of Long Term Debt-164.37-232.29-3.110.000.000.00-78.79-21.820.00
Net Financing Active Other Cash Flow0.000.000.000.00-1.34-6.29-1.62-1.71-13.92
Other Financing Activities Uses0.000.000.000.00-1.34-6.29-1.62-1.71-13.92
Cash from Financing Activities-163.76-235.78151.752.73-2.61264.08182.61231.3824.35
Exchange Rate Effect-0.010.03-0.030.02-0.01-0.010.030.01-
Net Change in Cash13.44-198.83143.37-10.04-76.92101.2773.92-10.405.45
Free Cash Flow6.99-20.02-1.33-46.27-50.42-40.22-35.37-34.58-42.57
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00--
Price to Free Cash Flow18.81--------
Deferred Taxes & Investment Tax Credit-0.080.080.01-4.52-7.13-1.270.040.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments78.99103.44108.8295.7391.5497.34
Short Term Receivables41.5342.1059.4559.4360.4168.78
Inventories0.000.000.000.000.000.00
Other Current Assets10.94101.2512.0412.3511.3012.76
Total Current Assets131.47246.79180.31167.51163.25178.88
Net Property, Plant & Equipment40.0639.4141.1940.4839.8745.74
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets61.1867.22182.58286.75375.14384.44
Other Assets4.715.188.127.918.877.12
Total Assets237.42358.60412.20502.64587.13616.18
Short Term Debt Incl. Current Port. of LT Debt3.665.335.365.415.485.50
Accounts Payable6.538.3411.699.364.948.94
Other Current Liabilities67.9678.2690.5674.8077.4784.38
Total Current Liabilities78.1591.92107.6189.5787.8998.82
Long Term Debt12.09164.65165.22165.83166.64167.28
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities1.591.201.221.460.682.53
Total Liabilities91.83257.78274.06256.86255.21268.63
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity145.59100.83138.15245.78331.92347.55
Total Shareholders Equity145.59100.83138.15245.78331.92347.55
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity145.59100.83138.15245.78331.92347.55
Total Liabilities & Stockholders Equity237.42358.60412.20502.64587.13616.18
Book Value Per Share1.911.351.873.414.704.95
Tangible Book Value Per Share1.110.45-0.60-0.57-0.61-0.53
Full-Time Employees---1,200--
Price to Book Ratio0.751.060.370.510.580.70
Return on Assets-49.02-54.33-40.69-26.14-15.37-15.31
Return on Equity-84.64-118.12-103.02-58.26-31.33-28.42
Return on Invested Capital25.68-15.27-36.60-22.11-4.46-7.96
Quick Ratio1.682.681.681.871.861.81
Current Ratio1.682.681.681.871.861.81

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income40.50-40.54-111.03-91.03-22.23-40.98
Depreciation9.7310.9812.1212.8812.6112.68
Other Funds (Non Cash)-51.8930.78101.0986.8713.9433.34
Funds from Operations-2.001.282.228.924.374.83
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.12-1.0116.290.99-4.83-13.82
Cash from Operating Activities-1.880.2818.519.91-0.46-9.00
Capital Expenditures-4.38-5.46-5.50-5.60-5.13-5.49
Net Assets From Acquisitions0.000.000.000.000.000.01
Sale of Fixed Assets and Businesses144.470.010.000.010.010.02
Purchase or Sale of Investments17.806.35-3.926.59-4.22-46.76
Purchase of Investments-0.00-18.75-24.91-7.91-10.46-46.76
Sale Or Maturity of Investments17.8025.1021.0014.506.240.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities157.890.90-9.411.01-9.35-52.23
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.27-0.040.40-0.030.530.31
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.27-0.040.40-0.030.530.31
Proceedsfrom Stock Options0.27-0.040.40-0.030.530.31
Issuance or Reduction of Debt, Net-163.15-0.41-0.41-0.41-1.07-230.41
Change in Long Term Debt-163.15-0.41-0.41-0.41-1.07-230.41
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-163.15-0.41-0.41-0.41-1.07-230.41
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-162.88-0.45-0.00-0.43-0.54-230.10
Exchange Rate Effect0.02-0.00-0.050.02-0.050.07
Net Change in Cash-6.840.729.0510.51-10.41-291.26
Free Cash Flow-6.21-4.8813.574.50-5.27-14.19
Price to Free Cash Flow18.8118.59----

Revenue breakdown

Professional Services2024: 111.73M 2025: 102.86M
Recurring Technology2024: 194.85M 2025: 208.28M
United States2024: 306.58M 2025: 311.14M
Professional Services2024: 111.73M 2025: 102.86M
Technology2024: 194.85M 2025: 208.28M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.28%2.0M59.6M587.39K
2026-10-153.51%2.1M58.9M626.85K
2026-09-303.75%2.2M59.0M707.55K
2026-09-153.44%2.0M59.0M991.68K
2026-08-313.16%2.0M61.8M1.61M
2026-08-143.72%2.3M61.5M1.64M
2026-07-314.79%3.0M62.3M1.51M
2026-07-155.95%3.6M61.2M1.54M
2026-06-307.45%4.6M61.7M1.47M
2026-06-1510.30%6.3M61.7M1.25M
2026-05-2910.70%6.6M61.6M714.24K
2026-05-1511.76%7.2M61.3M802.61K
2026-04-3011.93%7.6M63.6M847.35K
2026-04-1511.89%7.6M63.6M865.31K
2026-03-3111.84%7.7M64.9M851.73K
2026-03-1311.35%7.4M64.9M798.22K
2026-02-2710.82%6.8M62.4M738.82K
2026-02-139.16%5.7M62.4M690.07K
2026-01-308.01%5.0M62.4M670.65K
2026-01-158.12%5.1M62.4M658.04K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.651.350.0020.4250.000.000.937-0.0200.000
call1.000.150.800.827.7841.000.000.805-0.0210.001
call1.500.000.750.009.3470.000.000.747-0.0360.001
call2.000.000.750.1810.5211010.000.734-0.0440.001
call2.500.000.100.103.8708.000.000.257-0.0150.001
call5.000.000.750.006.0200.000.000.196-0.0210.001
call7.500.000.750.007.1450.000.000.178-0.0230.001
put0.500.000.600.0012.7830.000.00-0.064-0.0200.000
put1.000.000.250.005.9980.000.00-0.195-0.0210.001
put1.500.000.700.107.7631.000.00-0.255-0.0350.001
put2.000.200.900.385.6181.000.00-0.266-0.0430.001
put2.500.701.400.006.4740.000.00-0.743-0.0150.001
put5.003.004.100.0011.2260.000.00-0.804-0.0200.001
put7.505.406.800.0014.9260.000.00-0.822-0.0230.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-053Initial statement of beneficial ownership of securities2026-10-01SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-163Initial statement of beneficial ownership of securities2026-09-14SEC
2026-09-14S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-09-148-KCurrent report2026-09-11SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-09-088-KCurrent report2026-09-04SEC
2026-09-08SCHEDULE 13D/ASEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-07-31SEC
2026-07-28SCHEDULE 13G/ASEC
2026-07-21SCHEDULE 13GSEC
2026-07-204Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-204Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-208-KCurrent report2026-07-16SEC
2026-07-204Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-07-204Statement of changes in beneficial ownership of securities2026-07-16SEC
2026-06-22SCHEDULE 13DSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09105.44K100
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-1200200.68K2
2025-110000

Institutional holders

Manager% owned
First Light Asset Management, LLC17.34%
Palogic Value Management, L.P.13.32%
CDC Financial, Inc.9.60%
Impax Asset Management Group plc5.32%
VANGUARD CAPITAL MANAGEMENT LLC4.02%
Nepsis Inc.3.97%
BlackRock, Inc.2.49%
JANE STREET GROUP, LLC1.40%
ACADIAN ASSET MANAGEMENT LLC1.40%
HighMark Wealth Management LLC1.18%

Funds

Fund% owned
Impax Small Cap Fund5.41%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.79%
VANGUARD EXTENDED MARKET INDEX FUND1.07%
Fidelity Small Cap Index Fund0.85%
Fidelity Enhanced Small Cap Core ETF0.53%
Schwab U.S. Small-Cap ETF0.46%
VANGUARD RUSSELL 2000 INDEX FUND0.44%
PRIMECAP Odyssey Aggressive Growth Fund0.40%
Fidelity Extended Market Index Fund0.34%
iShares Micro-Cap ETF0.24%

OakChart. HCAT. Cached 15 minutes.